Patient Monitoring Devices Market worth $65.4 billion - Leading Key Players are Abbott Laboratories (US), HILL-ROM HOLDINGS, INC. (US), Drägerwerk AG & Co. KGaA (Germany), Edwards Lifesciences Corporation (US)

Patient Monitoring Devices Market is projected to grow from USD 42.3 billion in 2022 to USD 65.4 billion by 2027, at a CAGR of 9.1% from 2022 to 2027, according to a new report by MarketsandMarkets™. The evolution of the market is primarily driven by the rising number of hospitals across major markets, growing cognizance about vital parameter monitoring for treatment and analysis of chronic diseases coupled with the growing adoption of wireless and wearable patient monitoring devices for homecare. Additionally, expansion of developmental pipeline of OEMs for connected care & integrated/multi-parameter patient monitoring devices is poised to further augment the market growth in coming decade.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=678

Browse in-depth TOC on "Patient Monitoring Devices Market"
349 - Tables
41 - Figures
391 - Pages

Based on the product, the patient monitoring devices market is segmented into hemodynamic/pressure monitoring devices, multiparameter monitoring devices, neuromonitoring devices, fetal and neonatal monitoring devices, blood glucose monitoring systems, weight monitoring devices, respiratory monitoring devices, temperature monitoring devices, cardiac monitoring devices, and other patient monitoring devices. The cardiac monitoring devices products segment is further classified into smart/wearable ECG monitors, event monitors, ECG devices, mobile cardiac telemetry (MCT) monitors, and implantable loop recorders (ILRs). Within the cardiac monitoring devices products, the ECG devices division held a major part of the market in 2021. Emerging use cases of ECG devices and higher adoption of portable or wireless cardiac monitors are a major factor influencing to the growth of this market segment.

The hospital end user segment is expected to indicate the highest growth rate during the forecast period.

Based on end users, the patient monitoring devices market has been segmented into hospitals, ambulatory surgery centers, home care settings and other end users, Dominant market position of the hospitals segment can be credited to the presence of well-equipped emergency wards and ICUs in hospitals and the rising number of surgeries.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=678

North America is likely to lead the global patient monitoring devices market in 2021.

North America, encompassing the US and Canada, reported for the major split of the patient monitoring devices market in 2021. An growing quantity of clinical trials verifying patient monitoring devices and a rising amount of approvals for patient monitoring. Are the major factors driving market growth in North America. Customers in North America are shifting towards homecare patient monitoring, that requires non-invasive patient monitoring devices. This trend will have a definite impact on the patient monitoring device market.

As of 2021, Abbott Laboratories (US), HILL-ROM HOLDINGS, INC. (US), Drägerwerk AG & Co. KGaA (Germany), Edwards Lifesciences Corporation (US), OMRON Corporation (Japan), Masimo Corporation (US), Compumedics Limited (Australia), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Nihon Kohden Corporation (Japan), Natus Medical (US), Medtronic plc (Ireland), Koninklijke Philips N.V. (Netherlands), GE Healthcare (US), Getinge AB (Sweden), Boston Scientific Corporation (US), Dexcom, Inc. (US), Nonin (US), BIOTRONIK (Germany), SCHILLER (Switzerland), and BioTelemetry, Inc. (the US), among others are some of the major players operating in the global patient monitoring devices market.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=678

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

This release was published on openPR.